Research Grand Rounds: Alzheimer’s Disease Spectrum Trials: Where Are We Now? – March 13, 2020

Research Grand Rounds are sponsored by MedStar Health Research Institute and Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) and bring together the MedStar Health community for a learning experience focusing on a different topic each month.

On behalf of the Georgetown-Howard Universities Center for Clinical and Translational Science, and MedStar Health Research Institute, you are invited to Clinical and Translational Research Grand Rounds on Friday, March 13, 2020 from 12:00pm to 1:00pm. The speaker this month will be R. Scott Turner, MD, PhD. The Talk is titled, “Alzheimer’s Disease Spectrum Trials: Where Are We Now?

Dr. Turner is a Professor of Neurology and Director of the Memory Disorders Program at Georgetown University. His clinical and translational research focuses on prediction, diagnosis, prevention and treatment of Alzheimer’s Disease and Related Dementias, including imaging and biomarker studies, mechanistic studies, and clinical trials. He will present recent research findings - including results of a randomized, double-blind, placebo-controlled, single-site Phase 2a trial of nilotinib for Alzheimer's disease (submitted for publication).

Alzheimer’s Disease Spectrum Trials: Where Are We Now?
R. Scott Turner, MD, PhD. 
Professor of Neurology and Director of the Memory Disorders Program at Georgetown University

March 13, 2020

12 Noon to 1 PM – Presentation

Please note that this month’s talk will be streamed online, and we will not meet in person.
Live Stream Link: https://georgetown.zoom.us/j/482085870

If you have any questions regarding the Research Grand Rounds program, please contact [email protected] or visit www.georgetownhowardctsa.org